SEC Filing Summary

Jaime Vieser, a director at Alaunos Therapeutics, Inc., acquired 22,669 shares of common stock on October 6, 2026, at a price of $0.7444 per share. This acquisition was in lieu of board fees. Following the transaction, Vieser directly owns 70,311 shares. Additionally, Vieser has indirect ownership of 2,100 shares held by their children and 13,503 shares held by Brushwood LLC, where Vieser serves as Manager.